Carlsmed, Inc. (CARL)

NMS – Real vaqt narxi. Valyuta: USD

11.76

+0.52 (4.63%)

Yopilishda: Jun 26, 2026, 4:00 PM EDT

11.76

0.00 (0.00%)

Bozordan keyin: Jun 26, 2026, 4:31 PM EDT

25.05.2026

Wall Street Analysts See a 51.94% Upside in Carlsmed, Inc. (CARL): Can the Stock Really Move This High?

The consensus price target hints at a 51.9% upside potential for Carlsmed, Inc. (CARL). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.

13.05.2026

Carlsmed, Inc. (CARL) Presents at Bank of America Global Healthcare Conference 2026 Transcript

08.05.2026

Wall Street Analysts Think Carlsmed, Inc. (CARL) Could Surge 90.77%: Read This Before Placing a Bet

The mean of analysts' price targets for Carlsmed, Inc. (CARL) points to a 90.8% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

06.05.2026

Carlsmed, Inc. (CARL) Q1 2026 Earnings Call Transcript

05.05.2026

Carlsmed, Inc. (CARL) Reports Q1 Loss, Tops Revenue Estimates

Carlsmed, Inc. (CARL) came out with a quarterly loss of $0.32 per share versus the Zacks Consensus Estimate of a loss of $0.43. This compares to a loss of $1.47 per share a year ago.

05.05.2026

Carlsmed® Reports First Quarter 2026 Financial Results

First quarter 2026 revenue of $16.1 million, representing 58% growth year-over-year Full year 2026 revenue guidance raised to $72 million to $77 million CARLSBAD, Calif., May 05, 2026 (GLOBE NEWSWIRE) -- Carlsmed, Inc. (Nasdaq: CARL) (“Carlsmed” or the “Company”), a medical technology company pioneering AI-enabled personalized spine surgery solutions, today reported financial results for the first quarter ended March 31, 2026.

28.04.2026

Carlsmed, Inc. To Participate in Upcoming Investor Conferences

CARLSBAD, Calif., April 28, 2026 (GLOBE NEWSWIRE) -- Carlsmed, Inc. (Nasdaq: CARL) (“Carlsmed” or the “Company”), today announced that Mike Cordonnier, Chairman and Chief Executive Officer, will participate in the following investor conferences.

Videolar

No Data

There is no data to display

Press-relizlar

05.05.2026

Carlsmed® Reports First Quarter 2026 Financial Results

25.02.2026

Carlsmed® Reports Fourth Quarter and Full Year 2025 Financial Results

Fourth quarter revenue of $15.2 million; 61% growth YoY Full year revenue of $50.5 million; 86% growth YoY CARLSBAD, Calif., Feb. 25, 2026 (GLOBE NEWSWIRE) -- Carlsmed, Inc. (Nasdaq: CARL) (“Carlsmed” or the “Company”), a medical technology company pioneering AI-enabled personalized spine surgery solutions, today reported financial results for the fourth quarter and full year ended December 31, 2025.

23.02.2026

Carlsmed, Inc. To Participate in the 2026 Canaccord Genuity Musculoskeletal Conference

CARLSBAD, Calif., Feb. 23, 2026 (GLOBE NEWSWIRE) -- Carlsmed, Inc. (Nasdaq: CARL) (“Carlsmed” or the “Company”), today announced that Mike Cordonnier, CEO and Chairman, will be presenting at the 2026 Canaccord Genuity Musculoskeletal Conference on March 2, 2026 at 11:30 AM CST in New Orleans, LA.

18.02.2026

Carlsmed Announces first corra™ personalized Cervical Plating Procedure

The corra™ Cervical Plating System marks the debut of Carlsmed's patient-specific fixation portfolio The corra™ Cervical Plating System marks the debut of Carlsmed's patient-specific fixation portfolio

Carlsmed, Inc. (CARL)

Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling

Finranks

Kompaniya

Biz bilan bog'lanish

Bizni kuzating

Carlsmed, Inc. (CARL)

Wall Street Analysts See a 51.94% Upside in Carlsmed, Inc. (CARL): Can the Stock Really Move This High?

Carlsmed, Inc. (CARL) Presents at Bank of America Global Healthcare Conference 2026 Transcript

Wall Street Analysts Think Carlsmed, Inc. (CARL) Could Surge 90.77%: Read This Before Placing a Bet

Carlsmed, Inc. (CARL) Q1 2026 Earnings Call Transcript

Carlsmed, Inc. (CARL) Reports Q1 Loss, Tops Revenue Estimates

Carlsmed® Reports First Quarter 2026 Financial Results

Carlsmed, Inc. To Participate in Upcoming Investor Conferences

Videolar

No Data

Press-relizlar

Carlsmed® Reports First Quarter 2026 Financial Results

Carlsmed® Reports Fourth Quarter and Full Year 2025 Financial Results

Carlsmed, Inc. To Participate in the 2026 Canaccord Genuity Musculoskeletal Conference

Carlsmed Announces first corra™ personalized Cervical Plating Procedure

Wall Street Analysts See a 51.94% Upside in Carlsmed, Inc. (CARL): Can the Stock Really Move This High?

Carlsmed, Inc. (CARL) Presents at Bank of America Global Healthcare Conference 2026 Transcript

Wall Street Analysts Think Carlsmed, Inc. (CARL) Could Surge 90.77%: Read This Before Placing a Bet

Carlsmed, Inc. (CARL) Q1 2026 Earnings Call Transcript

Carlsmed, Inc. (CARL) Reports Q1 Loss, Tops Revenue Estimates

Carlsmed® Reports First Quarter 2026 Financial Results

Carlsmed, Inc. To Participate in Upcoming Investor Conferences

Videolar

No Data

Press-relizlar

Carlsmed® Reports First Quarter 2026 Financial Results

Carlsmed® Reports Fourth Quarter and Full Year 2025 Financial Results

Carlsmed, Inc. To Participate in the 2026 Canaccord Genuity Musculoskeletal Conference

Carlsmed Announces first corra™ personalized Cervical Plating Procedure

Search stocks

Carlsmed, Inc. (CARL)

Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling

Finranks

Kompaniya

Biz bilan bog'lanish

Bizni kuzating

Carlsmed, Inc. (CARL)

Wall Street Analysts See a 51.94% Upside in Carlsmed, Inc. (CARL): Can the Stock Really Move This High?

Carlsmed, Inc. (CARL) Presents at Bank of America Global Healthcare Conference 2026 Transcript

Wall Street Analysts Think Carlsmed, Inc. (CARL) Could Surge 90.77%: Read This Before Placing a Bet

Carlsmed, Inc. (CARL) Q1 2026 Earnings Call Transcript

Carlsmed, Inc. (CARL) Reports Q1 Loss, Tops Revenue Estimates

Carlsmed® Reports First Quarter 2026 Financial Results

Carlsmed, Inc. To Participate in Upcoming Investor Conferences

Videolar

No Data

Press-relizlar

Carlsmed® Reports First Quarter 2026 Financial Results

Carlsmed® Reports Fourth Quarter and Full Year 2025 Financial Results

Carlsmed, Inc. To Participate in the 2026 Canaccord Genuity Musculoskeletal Conference

Carlsmed Announces first corra™ personalized Cervical Plating Procedure

Wall Street Analysts See a 51.94% Upside in Carlsmed, Inc. (CARL): Can the Stock Really Move This High?

Carlsmed, Inc. (CARL) Presents at Bank of America Global Healthcare Conference 2026 Transcript

Wall Street Analysts Think Carlsmed, Inc. (CARL) Could Surge 90.77%: Read This Before Placing a Bet

Carlsmed, Inc. (CARL) Q1 2026 Earnings Call Transcript

Carlsmed, Inc. (CARL) Reports Q1 Loss, Tops Revenue Estimates

Carlsmed® Reports First Quarter 2026 Financial Results

Carlsmed, Inc. To Participate in Upcoming Investor Conferences

Videolar

No Data

Press-relizlar

Carlsmed® Reports First Quarter 2026 Financial Results

Carlsmed® Reports Fourth Quarter and Full Year 2025 Financial Results

Carlsmed, Inc. To Participate in the 2026 Canaccord Genuity Musculoskeletal Conference

Carlsmed Announces first corra™ personalized Cervical Plating Procedure